In a groundbreaking study led by the University of Washington, researchers have unearthed intriguing differences in the behavior of immune cells within the brains...
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four or more migraine days...
All right people, let’s do this one more time.If you’ve been following longevity research, you already know the story: young blood, either directly infused...
Hanna, J. H., Saha, K. & Jaenisch, R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143, 508–525 (2010).Article CAS PubMed PubMed Central ...
ARTICLE | DealsPlus: Approval for Pfizer’s MM bispecific and updates from Harmony-Zynerba, One Bio-Hengrui, Taysha, Arcturus, BioXcel By BioCentury Staff
August 15, 2023 12:16 AM UTC
Discussions...
